SANMARINE
DEAD

Serial Number

97583915

Owner

SANMARINE

First Use Date

Apr 20, 2019

Filing Date

Sep 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SANMARINE Trademark

Serial Number: 97583915

SANMARINE is a trademark filed by SANMARINE on September 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SANMARINE (2 trademarks)

1968 S COAST HWY, STE 1513
LAGUNA BEACH, CA 92651

Entity Type: 03

Trademark Details

Filing Date

September 8, 2022

Registration Date

Not Registered

First Use Anywhere

April 20, 2019

First Use in Commerce

October 15, 2021

Goods & Services

Dietary supplements; Medicines for adjusting the menstrual cycle; Medicines for alleviating constipation; Medicines for dental purposes; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Medicines made of Chinese traditional medicinal herbs; Vaccine preparations; Allergy tablets; Anaesthetics; Anesthetic for surgical purposes; Anti-inflammatory gels; Anti-inflammatory salves; Antiallergic medicines; Antidiarrheal medicines; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Bone wax for use in surgical procedures; Diagnostic preparations for medical purposes; Dietary supplements for human consumption; Injectable dermal filler; Injectable dermal fillers; Liquid nutritional supplement; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal drinks; Medicinal herbs; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal tea; Mineral nutritional supplements; Motion sickness medicines; Natural herbal supplements; Natural supplements for treating candida; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, dantrolene sodium for injection; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Radioactive substances for use in nuclear medicine; Sleeping pills/tablets; Stem cells for medical or veterinary use; Sulphonamides as medicines; Urinal deodorizer blocks; Vitamin tablets; Vitamin enriched bread for therapeutic purposes; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplements

Beauty salon services; Cosmetology services; Alternative medicine services; Alternative medicine services, namely, detoxification services; Alternative medicine services, namely, ear candling; Barber shop services; Emergency medicine clinics; Health clinic services; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care; Medical clinic services; Medical clinics; Providing medical aesthetic procedures, namely, treating the skin with dermal fillers and botulinum toxin; Providing news and information in the field of medicine; Regenerative medicine services; Rental of machines and apparatus for use in beauty salons or barbers' shops; Sports medicine services; Walk-in medical clinic services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 22, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 22, 2024 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 6, 2024 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Apr 6, 2024 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Apr 6, 2024 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 1, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 5, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 5, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 5, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2023 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
ASSIGNED TO LIE
Nov 28, 2023 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2023 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2022 NWOS
NEW APPLICATION ENTERED
Sep 12, 2022 NWAP